The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 166,494 | 82,423 | SH | SOLE | 82,423 | 0 | 0 | |||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 121,693 | 115,898 | SH | SOLE | 115,898 | 0 | 0 | |||
ALPHABET INC | CAP STK CL C | 02079K107 | 14,093 | 100 | SH | SOLE | 100 | 0 | 0 | |||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 206,080 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | |||
ARDELYX INC | COM | 039697107 | 7,140,335 | 1,151,667 | SH | SOLE | 1,151,667 | 0 | 0 | |||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 1,129,600 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
BATTALION OIL CORPORATION | COM | 07134L107 | 2,135,169 | 222,182 | SH | SOLE | 222,182 | 0 | 0 | |||
BLUEBIRD BIO INC | COM | 09609G100 | 733,133 | 531,256 | SH | SOLE | 531,256 | 0 | 0 | |||
BURGERFI INTERNATIONAL INC | COM | 12122L101 | 2,361,232 | 2,745,938 | SH | SOLE | 2,745,938 | 0 | 0 | |||
BURGERFI INTERNATIONAL INC | *W EXP 12/16/202 | 12122L119 | 93,755 | 2,083,438 | SH | SOLE | 2,083,438 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,946,879 | 82,425 | SH | SOLE | 82,425 | 0 | 0 | |||
ENPHYS ACQUISITION CORP | CL A ORD SHS | G3167L109 | 833,594 | 78,125 | SH | SOLE | 78,125 | 0 | 0 | |||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 1,234,200 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
HARPOON THERAPEUTICS INC | COM NEW | 41358P205 | 2,602,593 | 228,900 | SH | SOLE | 228,900 | 0 | 0 | |||
HUMACYTE INC | COM | 44486Q103 | 667,400 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 2,179,682 | 70,335 | SH | SOLE | 70,335 | 0 | 0 | |||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 33,117,150 | 165,000 | SH | Put | SOLE | 165,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 2,292,320 | 130,691 | SH | SOLE | 130,691 | 0 | 0 | |||
LUMOS PHARMA INC | COM | 55028X109 | 288,725 | 90,794 | SH | SOLE | 90,794 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 23,200,243 | 2,134,337 | SH | SOLE | 2,134,337 | 0 | 0 | |||
MICROSOFT CORP | COM | 594918104 | 37,604 | 100 | SH | SOLE | 100 | 0 | 0 | |||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 2,755,846 | 1,650,207 | SH | SOLE | 1,650,207 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 398,520 | 13,500 | SH | SOLE | 13,500 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 358,275 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | |||
SEMTECH CORP | COM | 816850101 | 56,480,803 | 2,577,855 | SH | SOLE | 2,577,855 | 0 | 0 | |||
SEMTECH CORP | COM | 816850101 | 54,775,000 | 2,500,000 | SH | Call | SOLE | 2,500,000 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 477,065 | 340,761 | SH | SOLE | 340,761 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 745,545 | 34,500 | SH | SOLE | 34,500 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 701,220 | 78,000 | SH | SOLE | 78,000 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 670,740 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 |